Chemomab Therapeutics Ltd. Quarterly Return On Equity in % from Q4 2019 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2023.
  • Chemomab Therapeutics Ltd. Return On Equity for the quarter ending June 30, 2023 was -101 %, a 209% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2022 was -58.2 %, a 192% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2021 was -20 %, a 61% increase from 2020.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2020 was -51.2 %, a 56.9% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -101 -68.5 -209% Apr 1, 2023 Jun 30, 2023
Q1 2023 -77.9 -52.8 -210% Jan 1, 2023 Mar 31, 2023
Q4 2022 -58.2 -38.3 -192% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.4 -26.6 -141% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.7 -11.8 -56.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.2 +1.04 +3.97% Jan 1, 2022 Mar 31, 2022
Q4 2021 -20 +31.3 +61% Oct 1, 2021 Dec 31, 2021
Q3 2021 -18.8 +61.1 +76.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.9 +89.5 +81.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -26.2 +80.7 +75.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -51.2 +67.5 +56.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -80 Jul 1, 2020 Sep 30, 2020
Q2 2020 -110 Apr 1, 2020 Jun 30, 2020
Q1 2020 -107 Jan 1, 2020 Mar 31, 2020
Q4 2019 -119 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.